Mahendra Ankit, Haque Aftabul, Prabakaran Ponraj, Mackness Brian C, Fuller Thomas P, Liu Xiaohua, Kathuria Sagar V, Wang Yui-Hsi, Amatya Nilesh, Yu Xiaocong, Hopke Joern, Hoffmann Dietmar, Bric-Furlong Eva, Zhang Ningning, Cho Hyun-Suk, Zhang Ruijun, Sancho Jose, Saleh Jacqueline, Rao Sambasiva P, Wendt Maria, Chowdhury Partha S
Large Molecule Research, Sanofi, 49 New York Avenue, Framingham, MA, USA.
Immunology & Inflammation Research, Genomics Center, Sanofi, 270 Albany Street, Cambridge, MA, USA.
Commun Biol. 2022 Oct 30;5(1):1157. doi: 10.1038/s42003-022-04129-7.
Immunization based antibody discovery is plagued by the paucity of antigen-specific B cells. Identifying these cells is akin to finding needle in a haystack. Current and emerging technologies while effective, are limited in terms of capturing the antigen-specific repertoire. We report on the bulk purification of antigen-specific B-cells and the benefits it offers to various antibody discovery platforms. Using five different antigens, we show hit rates of 51-88%, compared to about 5% with conventional methods. We also show that this purification is highly efficient with loss of only about 2% antigen specific cells. Furthermore, we compared clones in which cognate chains are preserved with those from display libraries in which chains either from total B cells (TBC) or antigen-specific B cells (AgSC) underwent combinatorial pairing. We found that cognate chain paired clones and combinatorial clones from AgSC library had higher frequency of functional clones and showed greater diversity in sequence and paratope compared to clones from the TBC library. This antigen-specific B-cell selection technique exemplifies a process improvement with reduced cycle time and cost, by removing undesired clones prior to screening and increasing the chance of capturing desirable and rare functional clones in the repertoire.
基于免疫的抗体发现受到抗原特异性B细胞数量稀少的困扰。识别这些细胞无异于大海捞针。当前和新兴技术虽然有效,但在捕获抗原特异性库方面存在局限性。我们报告了抗原特异性B细胞的大量纯化及其为各种抗体发现平台带来的益处。使用五种不同的抗原,我们展示了51%至88%的命中率,而传统方法的命中率约为5%。我们还表明,这种纯化效率很高,仅损失约2%的抗原特异性细胞。此外,我们比较了同源链得以保留的克隆与来自展示文库的克隆,在展示文库中,来自总B细胞(TBC)或抗原特异性B细胞(AgSC)的链进行了组合配对。我们发现,与来自TBC文库的克隆相比,同源链配对克隆和来自AgSC文库的组合克隆具有更高频率的功能克隆,并且在序列和互补决定区方面表现出更大的多样性。这种抗原特异性B细胞选择技术体现了一种流程改进,通过在筛选前去除不需要的克隆,并增加在库中捕获理想和罕见功能克隆的机会,从而缩短了周期时间并降低了成本。